The PD-1/PD-L1 Checkpoint Blockade
Certain types of cancer—including some non-small cell lung cancers—abnormally overexpress PD-L1 on the surface of their cells.
Read MoreSearch Results for: lung cancer
Overcoming Immune Blockade in Non-Small Cell Lung Cancer
Progress and challenges are on the way to a blood-based assay for PD-L1.
Read More
Landmark 100,000 Genomes Project Reaches Halfway Milestone
The United Kingdom’s 100,000 Genomes Project, led by Genomics England and Illumina, has reached a major milestone by sequencing 50,000 genomes.
Read More
SeraCare Releases CNV-Specific Reference Material for Gene Amplification
SeraCare Life Sciences has expanded its suite of clinical genomics development, validation, and quality control tools with the launch of the Seraseq breast copy number variation (CNV) mix and Seraseq lung and brain CNV mix.
Read MoreThermo Fisher Scientific Expands Its Liquid Biopsy and Immunooncology Portfolio
Thermo Fisher Scientific has expanded its Oncomine portfolio with new assays for liquid biopsy and immunooncology.
Read More